CAMBRIDGE, Mass. & SALISBURY, England--(BUSINESS WIRE)--$KALV--KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of small molecule protease inhibitors, today announced that it will present a corporate overview at the following upcoming investor conferences: Stifel 2018 Healthcare Conference on Tuesday, November 13, 2018 at 10:15 a.m. EST in New York, NY; Jefferies London Healthcare Conference on Thursday,